IDERA PHARMACEUTICALS INC - COM PAR (IDRA)

CUSIP: 45168K405

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM PAR
Total 13F shares
11,305,184
Share change
-29,225,201
Total reported value
$100,689,455
Price per share
$8.91
Number of holders
67
Value change
-$260,428,748
Number of buys
62
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 45168K405?
CUSIP 45168K405 identifies IDRA - IDERA PHARMACEUTICALS INC - COM PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IDERA PHARMACEUTICALS INC - COM PAR (IDRA) as of Q3 2018

As of 30 Sep 2018, IDERA PHARMACEUTICALS INC - COM PAR (IDRA) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,305,184 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, BlackRock Inc., Vanguard Group Inc, Broadfin Capital, LLC, MILLENNIUM MANAGEMENT LLC, NATIXIS, STATE STREET CORP, FMR LLC, NORTHERN TRUST CORP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 67 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.